APS is divided into primary and secondary, where the first is uncommon, even though aPL per se can be determined in 1%–5% of the population, which only seldom leads to APS; a prevalence of 40–50 cases per 100,000 has been determined in a recent population‐based study [52, 53]. Here, FASLG is linked to autoimmune polyendocrinopathy.